# OnCo record nct05716087 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05716087/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05716087", "NCT05716087" ;
  schema:name "A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma"@en ;
  schema:description "A phase 2 trial of Rocbrutinib in mantle cell lymphoma, run by Guangzhou Lupeng Pharmaceutical Company LTD., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05716087/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05716087> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-02-21" ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rocbrutinib/> ;
  onco:companies <https://onco.cc/companies/lupeng-pharmaceuticals/> .